• Login
    View Item 
    •   UMB Digital Archive
    • School of Pharmacy
    • Dr. Peter Doshi
    • View Item
    •   UMB Digital Archive
    • School of Pharmacy
    • Dr. Peter Doshi
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    The wider role of regulatory scientists

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Doshi_BMJ_Role_Reg_Scientists.pdf
    Size:
    891.8Kb
    Format:
    PDF
    Download
    Author
    Doshi, Peter
    Godlee, Fiona
    Date
    2017-04-27
    Publisher
    BMJ Publishing Group
    Type
    Article
    
    Metadata
    Show full item record
    See at
    http://bmj.com/cgi/content/full/bmj.j1991?ijkey=BpVIzvF15k4WHLc&keytype=ref
    Description
    Subtitle: Why they must help us improve the evidence base; Editorial in which the authors discuss drug clinical trial data submitted to the US Food and Drug Administration and call for regulators to correct misleading information published in the medical literature.
    Citation
    Doshi, P. & Godlee, F. (2017). The wider role of regulatory scientists. BMJ, 357. DOI: 10.1136/bmj.j1991
    Keyword
    ethical responsibility of regulatory scientists
    Access to Information
    Clinical Trials as Topic
    Disclosure
    Social Responsibility
    United States. Food and Drug Administration--ethics
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/6593
    ae974a485f413a2113503eed53cd6c53
    10.1136/bmj.j1991
    Scopus Count
    Collections
    Dr. Peter Doshi

    entitlement

    Related articles

    • FDA approval of paroxetine for menopausal hot flushes.
    • Authors: Orleans RJ, Li L, Kim MJ, Guo J, Sobhan M, Soule L, Joffe HV
    • Issue date: 2014 May 8
    • Precautionary harm disclosure in clinical trials.
    • Authors: Wu KC
    • Issue date: 2009 Aug
    • COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
    • Authors: Voloshyna I, Kasselman LJ, Carsons SE, Littlefield MJ, Gomolin IH, De Leon J, Reiss AB
    • Issue date: 2017 Mar
    • Some key points emerging from the COX-2 controversy.
    • Authors: Urquhart J
    • Issue date: 2005 Mar
    • Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat.
    • Authors: Lázár B, Brenner GB, Makkos A, Balogh M, László SB, Al-Khrasani M, Hutka B, Bató E, Ostorházi E, Juhász J, Kemény Á, László T, Tiszlavicz L, Bihari Z, Giricz Z, Szabó D, Helyes Z, Ferdinandy P, Gyires K, Zádori ZS
    • Issue date: 2019 Mar 15
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.